Intracoronary administration of levosimendan in cardiac surgery patients [Sepelvaltimoihin annetun levosimendaanin vaikutuksia sydänleikkauspotilailla].

Trial Profile

Intracoronary administration of levosimendan in cardiac surgery patients [Sepelvaltimoihin annetun levosimendaanin vaikutuksia sydänleikkauspotilailla].

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Levosimendan (Primary)
  • Indications Left ventricular dysfunction
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 Apr 2012 New source identified and integrated (European Clinical Trials Database: EudraCT2011-002643-10).
    • 13 Apr 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 03 Jan 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top